The Ras-assocation domain family (RASSF) of tumor suppressor proteins until recently contained six proteins named RASSF1-6. Recently, four novel family members, RASSF7-10, have been identified by homology searches for RA-domain-containing proteins. These additional RASSF members are divergent and structurally distinct from RASSF1-6, containing an N-terminal RA domain and lacking the Sav/RASSF/Hpo (SARAH) domain. Here, we show that RASSF8 is ubiquitously expressed throughout the murine embryo and in normal human adult tissues. Functionally, RNAi-mediated knockdown of RASSF8 in non-small-cell lung cancer (NSCLC) cell lines, increased anchorage-independent growth in soft agar and enhanced tumor growth in severe combined immunodeficiency (SCID) mice. Furthermore, EdU staining of RASSF8-depleted cells showed growth suppression in a manner dependent on contact inhibition. We show that endogenous RASSF8 is not only found in the nucleus, but is also membrane associated at sites of cell-cell adhesion, co-localizing with the adherens junction (AJ) component b-catenin and binding to E-cadherin. Following RASSF8 depletion in two different lung cancer cell lines using alternative small interfering RNA (siRNA) sequences, we show that AJs are destabilized and E-cadherin is lost from the cell membrane. The AJ components b-catenin and p65 are also lost from sites of cell-cell contact and are relocalized to the nucleus with a concomitant increase in b-catenin-dependent and nuclear factorjB (NF-jB)-dependent signaling following RASSF8 depletion. RASSF8 may also be required to maintain actin -cytoskeletal organization since immunofluorescence analysis shows a striking disorganization of the actincytoskeleton following RASSF8 depletion. Accordingly, scratch wound healing studies show increased cellular migration in RASSF8-deficient cells. These results implicate RASSF8 as a tumor suppressor gene that is essential for maintaining AJs function in epithelial cells and have a role in epithelial cell migration.
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Introduction
The classical Ras-association domain family (RASSF1-6) are a group of Ras-effector molecules that contain a C-terminal Ras-association (RA) domain of the Ra1GDS/ AF-6 variety and a protein interaction domain known as the Sav/RASSF/Hippo (SARAH) domain (Scheel and Hofmann, 2003) . Several members of the RASSF family are involved in tumorigenesis as epigenetic inactivation of many isoforms is a frequent event across many tumor types (Hesson et al., 2007a) . Several RASSF members show functions consistent with roles as tumor suppressor proteins such as the regulation of apoptosis through interactions with pro-apoptotic proteins such as the mammalian Ser/Thr kinases 1 and 2 (MST1/2) and modulator of apoptosis 1 (MOAP-1), which are known to interact with residues within the Sav/RASSF/Hippo (SARAH) domain (Hesson et al., 2007b; Richter et al., 2009) . In addition, RASSF1A has a major role in the regulation of microtubule dynamics during mitotic progression and loss of RASSF1A results in RAN GTPase-dependent progression delay through pro-metaphase leading to genomic instability and aneuploidy Dallol et al., 2004 Dallol et al., , 2009 ). RASSF1A depletion has also been shown to result in reduced cell-cell adhesion and changes in morphology (Dallol et al., 2005) .
Recently, several additional RA-domain-containing family members have been identified and designated as N-terminal RASSF proteins (RASSF7-10) (Sherwood et al., 2008) . These comprise RASSF7 (also known as HRC1), RASSF8 (also known as HOJ-1 or C12ORF2), RASSF9 (also known as P-CIP1 or PAMCI) and RASSF10. These proteins are divergent and structurally distinct from RASSF1-6, contain an RA domain within their extreme N-termini and lack the Sav/RASSF/Hpo (SARAH) protein interaction domain. RASSF7-10 represent an evolutionarily conserved group of proteins with orthologs of all four in the lower vertebrate Xenopus laevis and a RASSF7/8 homolog in Drosophila melanogaster distinct from the RASSF1-6 Drosophila homologs. Little is known about the N-terminal RASSF7-10 proteins. Recently we have shown that Xenopus RASSF7 is a centrosome-associated protein and is required for completing mitosis (Sherwood et al., 2008) . There is some evidence suggesting that RASSF8 may act as a tumor suppressor gene in lung cancer (Falvella et al., 2006) . RASSF9 has been shown to bind RAS proteins and is linked to vesicle trafficking (Chen et al., 1998; RodriguezViciana et al., 2004) . Finally, RASSF10 is frequently and epigenetically inactivated in leukemia . In this report, we provide evidence that RASSF8 is a lung cancer tumor suppressor gene that regulates cell-cell adhesion and actin cytoskeleton organization by having a critical role in maintaining AJ stability.
Results

RASSF8 is ubiquitously expressed
In order to characterize RASSF8, we assessed RASSF8 expression in mouse embryos. RASSF8 mRNA expression was assessed by in situ hybridization in normal E15.5 mice embryos by using RASSF8 antisense probes. RASSF8 mRNA expression was observed in the major organs, including brain, heart, kidney, liver, lung and spinal cord (Figure 1a) . We also performed expression analysis on a range of adult normal human tissues. Using primers that amplify across exons 4-6, we found that the RASSF8 gene is expressed in all tissues analyzed, including the lung (Supplementary Figure  S1A) . These studies illustrate the ubiquitous expression pattern of RASSF8 throughout murine embryos and normal human adult tissues, but very little is currently known about the role and function of RASSF8 in these tissues. In situ hybridization to assess RASSF8 RNA expression in E15.5 embryonic mouse showed RASSF8 mRNA expression in several major organs, including the lung. Staining was seen with the antisense probe but not with the sense control. (b) A549-RASSF8-RNAi and A549-NSC cell lysates were subjected to western blotting to analyze RASSF8 expression. RASSF8 expression is knocked down in A549-RASSF8-RNAi lysates compared with NSC controls. Tubulin expression was assessed as a loading control (upper panel). A549 RNAi cells were cultured in soft agar for 5 weeks to assess anchorageindependent cell growth. The total number of colonies spread over 100 mm across was counted. This experiment was repeated on three separate occasions, mean and s.e.m. is shown as fold change compared to A549 NSC-RNAi cells. *Po0.05 (lower panel). 
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RASSF8 suppresses tumor cell growth
To observe the effects of loss of RASSF8 expression, A549 lung carcinoma cells were stably transfected with GFP-IRES-shRNAmir constructs specifically targeting RASSF8 or a non-silencing control non-silencing control (NSC) to generate A549-RASSF8-RNAi and A549-NSC (nonsilencing control) cells, respectively. Depletion of RASSF8 protein was verified by western blotting using an antibody directed against RASSF8 (Figure 1b, top panel) . Cells with RASSF8 depletion showed a 2.7-fold increase in anchorage-independent growth in soft agar when compared with A549 cells expressing RNAi NSC sequence (Figure 1b , bottom panel). Transient depletion of RASSF8 using alternative siRNA sequences also resulted in a threefold increase in anchorage-independent growth of the lung cancer cell line H1792 (Supplementary Figures S1B and C) .
RASSF8 depletion promotes in vivo tumorigenicity in severe combined immunodeficiency (SCID) mice A549-RASSF8-RNAi and A549-NSC cells were also inoculated into SCID mice to study tumor growth in vivo. RNAi stable cells were mixed with matrigel and inoculated into three mice. Solid tumor nodes were only formed at the inoculation point and their size was measured with calipers. Over the course of 52 days, solid tumors were detected for all the mice inoculated with the A549-RASSF8-RNAi cells but no tumors were observed for mice inoculated with A549-NSC cells (Figure 1c ). Thus, we have shown that RASSF8 may function as a tumor suppressor gene in vitro and more importantly in vivo. In the above experiments, 10 4 cells were inoculated into SCID mice and we did not see tumor formation in control mice. In other experiments, when we inoculated 10 7 or 10 6 cells we observed tumors in control mice. In fact if we could have kept the mice for longer than 52 days we would get tumors also in controls even with a lower number of cells. But because of the institutional guidelines for the SCID mouse experiments, we had to stop the procedure at 52 days.
RASSF8-depleted cells increase EdU incorporation in confluent cells
Preliminary growth curve data suggested that RASSF8-depleted cells continued to proliferate even after cells reach confluency whereas control cells did not, suggesting a reduction in contact-dependent growth inhibition. Hence, we examined EdU incorporation as an index of DNA synthesis in dividing cells. In A549 confluent cells, RASSF8-depleted cells showed significantly more EdU incorporation compared with control cells (Po0.001), while in subconfluent cells no differences were seen in percentage EdU incorporation between RASSF8-depleted and control cells (P ¼ 0.39) (Figure 1d ). Thus, RASSF8-depleted cells continue to divide rapidly post-confluency, indicating further loss of contact-dependent inhibition.
RASSF8 knockdown in Xenopus results in enhanced cell proliferation
To further determine the role of RASSF8 in cell proliferation in vivo, we performed morpholinomediated knockdown studies in X. laevis embryos. MO2 directed against RASSF8 substantially downregulated RASSF8 protein, MO1 also downregulated RASSF8 protein but to a much lesser extent then MO2, while control morpholinos had no effect on RASSF8 protein level (Supplementary Figure S1D , left panel). We counted the number of cells stained for phosphohistone H3 (a marker for cell proliferation) in each section. We noticed a significant increase in cell proliferation in RASSF8-depleted cells (MO2) compared with control cells (P ¼ 0.0465) (Supplementary Figure S1D , middle and right panels). Whereas MO1 proliferation increased slightly, this was not significant. Hence, the differences in cell proliferation directly reflect the amount of RASSF8 protein present. These data add further evidence to the role of RASSF8 in controlling cell proliferation.
RASSF8 localizes to AJs
In order to examine the cellular localization of endogenous RASSF8, parental A549 and H1792 lung cancer cells were immunostained and examined by confocal microscopy. In A549 parental cells, endogenous RASSF8 was observed within the nucleus and at the cell membrane specifically at sites of cell-cell contact ( 
RASSF8 depletion inhibits AJs formation
Adherens junctions are located at the points of contact between cells and are indispensible to both epithelial cell polarity and normal tissue architecture. AJs maintain cell-cell adhesion mediated through homotype interactions between E-cadherin molecules on neighboring cells. E-cadherin homodimers span the plasma membrane to interact with b-catenin, which binds E-cadherin cytoplasmic tails and forms a part of a complex consisting of a-catenin and p120 catenin that links E-cadherin to actin filaments. Disruption of AJs is thought to result in reduced cell-cell adhesion and to permit the increased motility of normal cells or the invasion and metastasis of cancer cells.
Given the localization of human RASSF8 at AJs, we hypothesized that RASSF8 may be involved in maintaining AJ formation and stability. Using immunofluorescence, we analyzed the subcellular distribution of E-cadherin in A549-RASSF8-RNAi and control cells. In A549-NSC cells, E-cadherin is localized to the cell periphery at cell-cell contacts. Following RASSF8 depletion, cells are more spread out, with E-cadherin staining relocalized from cell-cell contacts to diffuse staining of the cytoplasm (Figure 2b ). Loss of tight, intercellular contact is clearly observed. Western blotting analysis confirmed that the total levels of E-cadherin remain unchanged following RASSF8 depletion in A549 cells (Figure 2c ). Transient depletion of RASSF8 using alternative siRNA sequences in another lung cancer cell line, H1792, gave similar results (Supplementary Figures S3B and C) .
Endogenous RASSF8 interacts with endogenous E-cadherin
We investigated whether RASSF8 and E-cadherin directly interact in mammalian cells. Endogenous E-cadherin and RASSF8 were immunoprecipitated using specific antibodies against these proteins in parental A549 cells. As shown in Figure 2d , we could detect the presence of E-cadherin in RASSF8 immunoprecipitates. The interaction between E-cadherin and RASSF8 was also observed when we used E-cadherin antibody to immunoprecipitate the complex (Figure 2d ). This confirmed E-cadherin and RASSF8 do indeed interact at the endogenous level in mammalian cells.
b-Catenin and the canonical Wnt signaling pathway b-Catenin has two distinct functions. When located at the cell periphery, b-catenin is a major cytoplasmic component of AJs. However, b-catenin is also found in a cytoplasmic pool and can enter the nucleus to mediate the Wnt signaling pathway. The canonical Wnt/bcatenin pathway has a key role in embryogenesis and also in the malignant transformation of cells. The oncogenic properties of this pathway stem from the relocalization of b-catenin at the cell membrane to the nucleus, where it binds the T-cell factor/lymphoid enhancer factor (TCF-LEF) family of transcription factors to form a bipartite transcription factor, which facilitates the transcription of target genes. These target genes encode effector proteins that promote proliferation, invasion and inhibit apoptosis. In this way, regulation of b-catenin subcellular localization is an important mechanism in regulating the canonical Wnt/ b-catenin pathway.
As shown earlier, RASSF8 co-localizes with b-catenin at the cell periphery in parental A549 and H1792 lung cancer cells (Figure 2a and Supplementary Figure S3A) . The subcellular distribution of b-catenin was determined by confocal immunofluorescence in A549 RNAi cells. In NSC cells, b-catenin is localized to the cell periphery and involved in AJs. Following RASSF8 depletion, b-catenin is relocalized from cell-cell contacts and accumulates in the cytoplasm and nucleus (Figure 3a) . The same experiment was repeated following transient In order to analyze endogenous RASSF8 localization, parental A549 cells were fixed, stained with RASSF8 and b-catenin antibodies and a nuclear stain and then subjected to microscopy. Endogenous RASSF8 is found in the nucleus and cytoplasm, but is also localized to cell-cell junctions, where it colocalizes with b-catenin at adherens junctions (AJs). (b) A549-RNAi cells were subjected to epifluorescence immunostaining for E-cadherin. A549-NSC cells grow in well-organized colonies, with E-cadherin localized to cell-cell junctions. Following RASSF8 depletion, E-cadherin is lost from cell junctions and cells grow in a more dispersed manner. (c) A549-RASSF8-RNAi, and A549-NSC cell lysates were subjected to western blotting. No significant changes in E-cadherin expression were observed. Tubulin expression was assessed as a loading control. Blots are representative of four separate experiments. (d) Endogenous E-cadherin and RASSF8 were co-immunoprecipitated from parental A549 cell lysates with the respective antibodies and their interaction was monitored by western blot. Anti-Green fluorescent protein was used as a negative control.
siRNA depletion of RASSF8 in H1792 cells (using alternative siRNA sequences), which confirmed this observation (Supplementary Figure S3C) . Western blotting analysis confirmed that the total levels of b-catenin remain constant following RASSF8 depletion (Figure 3b and Supplementary Figure S3B ). In the nucleus, b-catenin can interact with the T-cell factor/lymphoid enhanced factor (TCF-LEF) family of transcription factors to facilitate the activation of target genes as part of the canonical Wnt signaling pathway. The activity of a b-catenin/TCF-dependent promoter (TOP) was determined in A549 RNAi cells. A significant increase in b-catenin/TCF-dependent promoter (TOP)-dependent promoter activity was observed following RASSF8 knockdown (Figure 3c ; Po0.01). Again, this result was confirmed following transient RASSF8 depletion in H1792 cells (Supplementary Figure S3D; Po0.001).
p65 localization at AJs is abolished following RASSF8 depletion The NF-kB family of transcription regulators is ubiquitously expressed in most eukaryotic cells and is found in the cytoplasm as homo-or heterodimers. Nuclear factor-kB (NF-kB) transcription factors are implicated in carcinogenesis and cellular transformation (Downward, 2009 ). All family members share a RELhomology domain (RHD), which is required for nuclear localization, DNA binding and interaction with the IkB regulatory proteins. The most well-characterized member of this family is NF-kB p65. It has been reported that the p65 subunit of the NF-kB heterodimer associates with b-catenin and other components of AJs (Deng et al., 2002; Solanas et al., 2008) . Indeed, b-catenin may also regulate the NF-kB signaling pathway in some cell types (Deng et al., 2004) . We also observed p65 localized to AJs, co-localizing with b-catenin in Figure S4A) . Previous work has shown that disruption of functional AJs can lead to relocation of p65 from the cell periphery to the nucleus, where it can promote NF-kBdependent transcription of target genes that encode promitotic and anti-apoptotic proteins (Deng et al., 2002) . Therefore, the importance of RASSF8 expression in regulating the subcellular distribution of p65 was determined by confocal immunofluorescence in A549 RNAi cells. In parental and NSC cells, p65 is localized to the cell periphery and co-localizes with b-catenin at AJs (Figures 4a and b) . Following RASSF8 depletion, p65 is relocalized from cell-cell contacts and accumulates in the cytoplasm and nucleus (Figure 4b ). Nuclear p65 increased 42.5-fold in RASSF8-depleted A549 cells (Supplementary Figure S5) . The same experiment was repeated following transient siRNA depletion of RASSF8 in H1792 cells, which confirmed this observation (Supplementary Figure S4B) .
NF-kB promoter-dependent signaling is increased following RASSF8 knockdown
The activity of an NF-kB-dependent promoter was determined in A549 RNAi and control cells. A significant increase in NF-kB-dependent promoter activity was observed following RASSF8 knockdown (Figure 4c ; Po0.01). This experiment was repeated using RASSF8 transient depletion in H1792, where RASSF8 knockdown again induced an increase in NF-kB-dependent promoter activity (Supplementary Figure S4C ; Po0.05).
p65 binds to target DNA sequences called kB sites found on the promoter and enhancer regions of target genes. At these sites, p65 can interact with a co-adapter and bridging proteins to transactivate a variety of genes (including c-myc, p53 and some cyclins) involved in cell cycle control to promote cellular transformation and inhibit apoptosis. In unstimulated cells, inactive NF-kBp65 dimeric complexes are bound to its regulatory protein IkB-a. Signal transduction leading to NF-kB-p65 activation is processed through IkB-a as IkB-a binding masks the nuclear localizing signal of NF-kB-p65 dimers. Cell stimulation leading to IkB-a dissociation from p65 also results in phosphorylation of IkB-a, targeting IkB-a for degradation by the 26S proteosome, and allowing p65 dimers to enter the nucleus (Hayden and Ghosh, 2008) .
IkB-a cellular levels in A549 cells were analyzed by western blotting. Following RASSF8-RNAi, IkB-a levels were significantly depleted, compared with NSC-RNAi controls (Figure 4d ). This result was also observed in H1792 cells following transient depletion of RASSF8 (Supplementary Figure S4D) . Hence, antibodies and examined by confocal microscopy. p65 is localized to the cell periphery, co-localizing with b-catenin at adherens junctions (AJs). (b) A549-RNAi cells were subjected to confocal immunostaining for p65. In A549-NSC cells p65 is localized to AJs at the cell periphery. Following RASSF8 depletion, p65 is lost from cell junctions and is relocalized to nuclear and perinuclear regions in the cell. (c) The activity of a NF-kB-dependent promoter was determined in A549 RNAi cells by luciferase assay. A549 RNAi cells were transiently transfected with 1 mg 3nehGL4.2 (p65 -dependent promoter activity reporter construct) and 0.1 mg of pRL-TK (Renilla Luciferase transfection control), cultured for 24 h, lysed and luciferase activity was analyzed. A significant increase in p65-dependent promoter activity was observed following RASSF8 knockdown. Data shown are the mean and s.e.m. from three separate experiments, expressed as fold change compared to A549-NSC-RNAi cells. **Po0.01. (d) A549-RNAi cellular levels of the p65 regulator IkB-a were analyzed by immunoblotting. Following RASSF8 knockdown, IkB-a levels were significantly decreased compared to NSC control cell lysates. Tubulin expression was also assessed as a loading control. This experiment was repeated on three separate occasions, with representative blots shown. Scale bar represents 10 mm in all immunofluorescence images.
RASSF8 depletion results in NF-kB activation in lung cancer cells.
RASSF8 is required for cytoskeleton organization
The observed changes in AJ formation and cell morphology following RASSF8 depletion led us to look at the morphology of the actin cytoskeleton in these cells. A549-RNAi cells were fixed and stained with alexa-phalloidin to visualize the actin cytoskeleton. A549-NSC cells have an organized actin cytoskeleton, with actin bundles and stress fibers clearly visible. Following RASSF8 depletion, the actin cytoskeletal architecture appears very disorganized, with few stress fibers seen (Figure 5a) . A similar change in actin cytoskeleton morphology was also observed in H1792 transiently transfected with RASSF8 siRNA (Supplementary Figure S6) . Having observed a significant change in actin morphology, we also assessed the in vitro migration ability of A549-RNAi cells using a scratch wound-healing assay. Seven hours after wounding, the area of the wound covered was assessed. A549-RASSF8-RNAi cells covered a significantly greater wound area, compared with the A549-NSC cells, suggesting that cell migration and motility are significantly increased following RASSF8 knockdown (Figure 5b and Supplementary Figure S7 ; Po0.001).
Discussion
RASSF8 is a novel tumor suppressor in vivo and in vitro RASSF8 represents an intriguing new member of the RASSF family. Here, we confirmed that RASSF8 mRNA is expressed in all the major organs and tissues, including the lung, during murine embryonic development and in normal adult human tissues. Closer examination by confocal immunofluorescence studies also revealed that RASSF8 is found in the nucleus and also concentrated at the cell membrane at the AJs in lung cancer cells.
It has been recently suggested that RASSF8 may be a novel tumor suppressor gene in lung cancer (Falvella et al., 2006) . Overexpression of this isoform suppresses anchorage-independent growth of the lung cancer cell lines A549 and H520 (Falvella et al., 2006) . As overexpression can often lead to toxicity, we aimed to investigate the effects of decreased levels of RASSF8 (as observed in lung cancer) on cell growth by RNAimediated RASSF8 depletion. Both transient and stable depletion of RASSF8 in H1792 and A549 lung cancer cells, respectively, resulted in accelerated anchorageindependent growth in soft agar providing further evidence that physiological levels of RASSF8 suppress cell growth. RASSF8-depleted A549 cells injected into SCID mice also resulted in increased tumor formation compared with mice injected with control cells, showing, for the first time, that physiological levels of RASSF8 are required to suppress tumor growth in vivo. Increase in cell proliferation was also seen in Xenopus embryos with RASSF8 depletion compared with control cells, providing further evidence for the role of RASSF8 acting as a tumor suppressor gene.
Proliferation studies of control A549 and RASSF8-depleted stable cells suggested similar rates of proliferation up to the point of confluency, after which RASSF8-depleted A549 cells continued to proliferate. Indeed, we show that RASSF8-depleted cells increase EdU incorporation in confluent cells but not in subconfluent cells. This suggests that RASSF8 suppresses growth in a manner dependent on contact inhibition, a physiological process whereby the proliferation of normal cells is limited by their physical contact with neighboring cells.
RASSF8 expression is required for AJ stability Endogenous RASSF8 localizes to AJs in lung cancer cells and binds to E-cadherin. Following RASSF8 depletion, E-cadherin total expression levels remain unchanged. However, E-cadherin localization is lost from the discrete localization at the cell membrane to diffuse staining within the cytoplasm. This observation was confirmed by confocal microscopy analysis of b-catenin staining. Following RASSF8 depletion, b-catenin is lost from AJs and accumulates in the cytoplasm and nucleus. This suggests that the AJ formation and function is lost following RASSF8 depletion. Lack of stabilization of b-catenin at AJs allows b-catenin relocalization to the nucleus, where it can promote activation of the canonical Wnt signaling pathway by interacting with the T-cell factor/lymphoid enhanced factor (TCF-LEF) family of transcription factors and facilitating the activation of TCF-dependent genes (Brembeck et al., 2006; MacDonald et al., 2009) . We observed a significant increase in b-catenin/ TCF-dependent promoter activity following RASSF8 depletion. Together, these data suggest that RASSF8 depletion may result in increased b-catenin/TCF signaling, as part of the canonical Wnt signaling pathway. It has been previously shown that disruption of functional AJs can lead to relocation of p65 from the cell periphery to the nucleus, where it can promote NF-kB-dependent transcription of target genes. Following RASSF8 depletion, we also observed a relocalization of p65 from AJs to the perinuclear and nuclear regions of the cell. Promoter activity analysis confirmed a significant increase in NF-kB-dependent promoter activity following RASSF8 knockdown. p65 signaling requires the regulatory protein IkB-a to be phosphorylated and degraded, allowing p65 dimers to enter the nucleus and activate target genes. Western blotting confirmed that IkB-a cellular levels were significantly depleted following RASSF8 depletion. Together, these data suggest that the NF-kB p65 signaling pathway is upregulated following RASSF8 depletion. The observed decrease in the level of IkB-a correlates with increased nuclear NF-kB and is likely a result of its phosphorylation by the multisubunit IkappaB kinase (IKK). The effect on RASSF8 knockdown on the mechanics of IkB-a regulation/degradation presents opportunities for future study.
Together, these findings suggest that RASSF8 expression may control cellular proliferation of non-small cell lung cancer (NSCLC) cells by regulating b-catenin localization and the canonical Wnt signaling pathway and, concomitantly, p65 localization and the NF-kB signaling pathway.
RASSF8 may have a role in actin cytoskeleton organization and cell motility In lung carcinoma cells, the actin cytoskeleton is organized into stress fibers, which span the cell cytoplasm, linking to the catenins in AJs to anchor at the cell membrane. The observed disruption of AJs following RASSF8 depletion is the likely cause of the observed disruption and disorganization of the actin cytoskeleton in these cells. We also observed a significant increase in cell motility following RASSF8 knockdown in A549 cells, which may be a functional consequence of the observed disorganization of the actin cytoskeleton. These data suggest that loss of RASSF8 expression may have an important role in stabilizing the actin cytoskeleton and thus repressing cell migration. RASSF8 has also been implicated in a familial form of synpolydactyly (Debeer et al., 2002) . A reciprocal chromosomal translocation t(12;22)(p11.2; q13.3) involving RASSF8 and the Fibulin-1 (FBLN1) gene was identified in three patients from one family sharing a complex type of synpolydactyly. It is at present unclear what role disruption of RASSF8 may have in the observed limb malformations. However, it is intriguing to speculate that the role of RASSF8 in regulating cell-cell adhesion may contribute to the development of normal tissue architecture.
A role for RASSF family members in controlling cell adhesion is not without precedence. An isoform of RASSF5 (also known as RAPL) regulates the redistribution of lymphocyte-function-associated antigen 1 (LFA-1) at the cell membrane to enhance adhesion to intercellular adhesion molecule 1 (ICAM-1) T-cell immunological synapses (Katagiri et al., 2003) . Furthermore, we previously showed that RASSF1A depletion results in changes in cell morphology, increased cellular migration and reduced cell-cell adhesion (Dallol et al., 2005) . These examples provide evidence that several members of the RASSF family are important adaptor proteins in signaling pathways that link the cytoskeletal framework of cells to cell membrane receptor complexes.
RASSF7 is the RASSF protein with the most sequence similarity to RASSF8. However, our results suggest that there are significant differences between the functions of RASSF7 and RASSF8. We show that RASSF8 localizes to sights of cell-cell contact and in the nucleus. In contrast RASSF7 localizes to the centrosome (Sherwood et al., 2008) . Knocking down RASSF7 in Xenopus embryos produced a striking increase in nuclear fragmentation (Sherwood et al., 2008) ; when we knocked down RASSF8 we did not see this fragmentation. In contrast, knocking down RASSF8 produced an increase in proliferation, something that was not seen after knocking down RASSF7 (Sherwood et al., 2008) . This suggests that the two genes have diverged in their function. In Drosophila, there is one gene that is related to RASSF7 and RASSF8, and it appears that the function of this gene is more similar to RASSF8 than RASSF7 (Langton et al., 2009) . Langton et al. have recently described the role of Drosophila dASPPdRASSF8 in regulating cell-cell adhesion during Drosophila retinal morphogenesis.
AJs are essential for maintaining tissue architecture. They are also involved in the maintenance of tissue homeostasis, promote cell-to-cell communication, increase resistance to apoptosis, regulate cell shape and polarity (Dejana and Rudini, 2008) . In this report, we have provided evidence that RASSF8 loss leads to enhanced cell proliferation in vivo and loss of AJ function, thereby deregulating the Wnt and NF-kB signaling pathways in cancer. Hence, a member of the N-terminal RASSF family may be essential for maintaining AJ function in epithelial cells.
Materials and methods
Cell culture
Cell culture medium and reagents were purchased from Invitrogen (Paisley, UK). A549 and H1792 were maintained at 37 1C, 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM), with 10% fetal calf serum (FCS), 1% penicillin/ streptomycin, 1% glutamine and 1% sodium pyruvate added.
A549-RNAi cell line production A549 were stably transfected with GFP-IRES-shRNAmir constructs purchased from Open Biosystems (Huntsville, AL, USA), to knock down RASSF8 (RHS3979-98827810: CCGGGCCTCAGATTGACAAATCAATCTCGAGATTGA TTTGTCAATCTGAGGCTTTTTTG) or a nonsense mRNA sequence (Non-Silencing Control) (pLKO.1) using Fugene HD (Roche, Burgess Hill, UK) according to the manufacturer's instructions and maintained in puromycin.
Antibodies
The antibodies used were as follows: anti-RASSF8 (Abnova, Heidelberg, Germany, H00011228-M01, Supplementary Figure S8 ), anti-tubulin (Abcam, Cambridge, UK, ab18251), b-catenin (Abcam, ab32572), E-cadherin (HECD-1, a kind gift from Neil Hotchin, University of Birmingham), NF-kB-p65, total IkB-a (C-21, Santa Cruz Biotechnology, Heidelberg, Germany) and alexa-phalloidin (Sigma, St Louis, MO, USA). Secondary antibodies were purchased from Jackson Immunoresearch (West Grove, PA, USA).
Immunocytochemistry A549 or H1792 cells cultured on acid-washed glass coverslips, were fixed with 4% para-formaldehyde in phosphate buffered saline (PBS) and stained with primary antibodies as specified in the text, then with appropriate secondary antibodies. Filamentous actin was visualized using phalloidin-Alexa594 (Sigma) with images inverted for clarity. For epifluorescence microscopy, cells were visualized using a Leica (Wetzlar, Germany) DMRB microscope equipped with a Hamamatsu (Welwyn Garden City, UK) ORCA camera and images were captured and processed using OpenLab software (Improvision-PerkinElmer, Cambridge, UK). For each immunostaining, the same exposure time was used to capture images. For confocal microscopy cells were visualized using a Zeiss LSM 510 confocal (Zeiss, Welwyn Garden City, UK) and images were captured and processed using LSM image browser software. All pictures were taken sequentially, with a line average of 4.
EdU incorporation assay
The EdU Click-it system (Invitrogen) was used as per the manufacturer's instructions to analyze proliferation as a measure of the percentage of cells going through S phase, under different experimental conditions, as specified in the text. The mean and the s.e.m. of three separate experiments, performed in triplicate, are shown. At least 1200 cells per experiment were counted, and the experiment repeated three times.
Mouse mRNA in situ hybridization In situ hybridization was carried out on E15.5 embryos and adult mouse tissues sections using sense and antisense probes as previously described (Charalambous et al., 2003) . The probes for RASSF8 were generated from a mouse Rassf8 containing pCRbluntII-topo vector (image clone: 40105476) using a T7 promoter (sense strand) or SP6 promoter (antisense) following digestion with EconI or PstI enzymes, respectively.
Luciferase reporter assay TOPflash (TCF Reporter) luciferase plasmid (Millipore, Watford, UK), FOPflash scrambled vector (Millipore), pGL3 basic empty vector (Promega, Southampton, UK) were used. The NF-kB-dependent promoter luciferase reporter vector 3nehGL4.2 was constructed by transferring three synthetic copies of the kB consensus of the immunoglobulin k-chain promoter sequence from the original 3enh vector. The 3enhkB promoter was amplified using forward primer (5 0 -TTAA GCTTTTTGCAAAAGCCTAGGCC-3 0 ) and reverse primer (5 0 -ATAGCTAGCAGCAGCCCAGTAGTAGG-3 0 ). The resulting PCR product was ligated into the pGEM T easy cloning vector (Promega) and then cloned into the pGL4.22 luciferase vector (Promega), where the luciferase is tagged with two degradation sequences to promote the degradation of luciferase and prevent toxic levels accumulating in the cell. Correct insertion was confirmed by plasmid sequencing. Cells were transiently transfected with 1 mg of either 3nehGL4.2 (p65 reporter), TOPFlash, FOPFlash (scrambled control) or pGL3-basic and 0.1 mg pRL TK using Fugene HD (ROCHE) according to the manufacturer's instructions. Firefly and renilla luciferase activities were assayed 24 h post-transfection using the dualreporter assay kit Stop 'N' Glow (Promega). Firefly luciferase activity was normalized to renilla luciferase activity as a transfection control. Promoter activity is expressed as relative luciferase activity compared with that obtained in pGL3basic or FOPFlash (scrambled) control transfected cells, as appropriate.
Soft agar growth assays
For transient knockdown of RASSF8 H1792, lung cancer cells were plated at 5 Â 10 4 cells per well of a six-well plate and treated with siRNA oligo directed against luciferase or against RASSF8 using oligofectamine (Invitrogen). Twenty-four hours later cells were trypsinized and plated at 0.5 Â 10 5 cells per well in soft agar in a six-well plate. Cells were cultured at 37 1C for 2 weeks, colonies were photographed, and the average number of colonies greater than 100 mm was calculated and expressed as fold change compared with luciferase siRNAtreated controls. Soft agar growth assay using A549 stable RNAi cells was maintained for 5 weeks at 37 1C; colonies were photographed and the average number of colonies greater than 100 mm was calculated expressed as fold change compared with NSC-RNAi-treated controls.
Scratch wound-healing studies Cells were plated at confluence onto glass-bottom culture dishes (MatTek Corporation, Ashland, MA, USA) and allowed to recover for 24 h at 37 1C, 5% CO 2 in normal culture media. Confluent monolayers were wounded with a sterile pipette tip and culture media replaced cell-imaging media (CIM) (10 mM HEPES-HBSS, pH 7.4, with 5% fetal bovine serum). Cells were imaged immediately and 7 h post-wounding at the same position using a Nikon TE300 epifluorescence microscope (Nikon, Amstelveen, The Netherlands). The acquisition and editing software used was Openlab 5.0 (Improvision, Coventry, UK). The extent of wound healing was defined as the remaining wound area over the original wound area. This experiment was performed for a minimum of three times, with the mean and s.e. shown.
In vivo tumor growth analysis
The tumorigenicity of each cell line was tested by subcutaneous injection of 10 4 cells in three 4-week-old female SCID mice, as described previously (Wang et al., 2008) . Tumor growth in animals was checked twice a week, if tumor formation was observed, tumors were measured using calipers.
Statistical analysis
Statistical analysis was performed using Student's t-test or Fisher's exact test. Po0.05 was considered significant.
